Global Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market size is expected to reach USD 2.65 Bn. by 2032, at a CAGR of  8.69% during the forecast period.

Veterinary Molecular Diagnostics Market Overview:

Molecular diagnostics is the assessment of a wide spectrum of animal pathogens using molecular techniques. Veterinary molecular diagnostic has a number of advantages over traditional methods, including a shorter testing time, a clearer separation between virulent and avirulent strains, and excellent specificity and sensitivity.To know about the Research Methodology :- Request Free Sample Report

Veterinary Molecular Diagnostics Market Dynamics:

Rising prevalence of zoonotic diseases is the major factor driving the market growth.

During the forecasted period, the rising prevalence of zoonotic illnesses is expected to fuel the growth of the veterinary molecular diagnostics market. Zoonotic infections are frequent in the United States and around the world, according to the CDC. According to CDC data, 6 out of every 10 new known infectious diseases in humans can be spread by animals, and 3 out of every 4 new or emerging infectious diseases in humans can be carried by animals. As a result, increasing attempts to minimise the spread of these viruses to humans include recognising disorders in animals and concentrating on their well-being. The global veterinary molecular diagnostics market is predicted to increase as a result of these factors.

The market for veterinary molecular diagnostic appears to be growing globally, owing to rising demand for animal-derived food, rising need for pet insurance, and rising animal health spending. Furthermore, rising pet adoption in both rich and developing countries is driving up animal healthcare costs. This has a beneficial impact on the veterinary molecular diagnostics market's growth. Fast FDA approvals for reagents used in molecular diagnostic, as well as robust distribution channels, are expected to propel the market forward. The animal healthcare industry is facing challenges from growing in economies such as China, India, Brazil, and parts of Southeast Asia. The high expense of veterinary molecular diagnosis, government rules for new product approvals, and a lack of epidemiological information of certain virulent diseases connected with animals, on the other hand, are limiting the market growth.

The report has profiled twenty four key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Veterinary Molecular Diagnostics Market Segment Analysis:

The Global Veterinary Molecular Diagnostics Market is segmented on the basis of Product, Application and Technology.

Based on Product, the kits and reagents segment is expected to dominate the global market. In the global veterinary molecular diagnostics market, kits account for the vast majority of commercial goods. These kits are mostly based on PCR techniques and aid in the screening of a group of illnesses that are related. Diagnostic kits and reagents are expected to develop rapidly due to their wide range of veterinary applications and high effectiveness and specificity. Many products based on immune-assays are projected to be approved for marketing over the projection period. Porcine Epidemic Diarrhea Virus (PEDv), Porcine Deltacoronavirus (PDCoV), and Transmissible Gastroenteritis Viral are examples of pathogen and virus detection assays that are integrated with PCR techniques (TGEV). CEVA and Biotecon Diagnostics will launch a real-time test kit in September 2025 to combat the growing problem of salmonella on pig farms.

Veterinary Molecular Diagnostics Market Regional Insights:

North America is expected to dominate the global market during forecast period.

The dominance of North America in the worldwide veterinary molecular diagnostics market is due to rising pet adoption in the United States and the presence of large companies. Furthermore, rising animal welfare awareness and increased efforts by organisations to promote animal welfare activities in the region are boosting the regional market's growth. Europe is the second-most lucrative region in the worldwide veterinary molecular diagnostics industry, behind North America. Increased government backing, high-quality diagnostic procedures, and the number of veterinary diagnostic centers will help the European veterinary molecular diagnostics industry grow.

Recent Industry Developments (2025–2026)

The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.

Veterinary Molecular Diagnostics Market Scope: Inquire before buying

Veterinary Molecular Diagnostics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)

Key players/ competitors profile covered in brief in Veterinary Molecular Diagnostics Market report in strategic perspective

1. Thermo Fisher Scientific
2. Zoetis
3. IDEXX Laboratories
4. Neogen Corporation
5. VCA Inc. (Mars, Incorporated)
6. Bio-Rad Laboratories
7. Virbac
8. HESKA Corporation
9. Agrolabo
10. Abaxis (Zoetis)
11. Nova-Tech
12. Randox Laboratories
13. Qiagen
14. Merck & Co.
15. Boehringer Ingelheim International GmbH
16. Indical Bioscience
17. Biotang
18. Eurofins Technologies
19. Seegene
20. Bioneer Corporation
21. Biomerieux
22. Gold Standard Diagnostics
23. Biogal Galed Labs
24. Veredus Laboratories
25. Ringbio